The EDUC8 is an Innovative Training Network (ITN) funded by the European Union Horizon 2020 Programme.
EDUC8 is composed of leading European scientists dedicated to understanding the immunogenicity of therapeutic pro-coagulant factor VIII (FVIII) in patients with haemophilia A (HA), a major societal concern owing its burden on patients health and quality of life, on clinical management and on European health systems.